Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 2/20 | 0.44 |
| ▸ | DRD4 | P21917 | 2/20 | 0.44 |
| ▸ | DRD3 | P35462 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.41 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.41 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.40 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8108347 | 1.00 | ALDH1A1 (0.45) | ALDH1A1THRBHPGDL3MBTL1DRD2 | |
| Hydrochloric Acid SCHEMBL3738666 | 0.98 | ALDH1A1 (0.44) | ALDH1A1THRBHPGDL3MBTL1DRD2 | |
| Bromide SCHEMBL3726981 | 0.98 | ALDH1A1 (0.44) | ALDH1A1THRBHPGDL3MBTL1DRD2 | |
| Dimethylamine SCHEMBL6948646 | 0.94 | ALDH1A1 (0.42) | ALDH1A1THRBHPGDL3MBTL1DRD2 | |
| Dimethylamine SCHEMBL8109560 | 0.94 | ALDH1A1 (0.42) | ALDH1A1THRBHPGDL3MBTL1DRD2 | |
| SCHEMBL2412116 | 0.93 | GNAI3 (0.48) | GNAI3GNAO1GNAI1S1PR1S1PR3 | |
| SCHEMBL3731537 | 0.91 | GNAI3 (0.52) | GNAI3GNAO1GNAI1S1PR1S1PR3 | |
| SCHEMBL3738816 | 0.91 | GNAI3 (0.52) | GNAI3GNAO1GNAI1S1PR1S1PR3 | |
| SCHEMBL8537776 | 0.91 | GNAI3 (0.52) | GNAI3GNAO1GNAI1S1PR1S1PR3 | |
| SCHEMBL3729275 | 0.91 | GNAI3 (0.52) | GNAI3GNAO1GNAI1S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118878789-A | Branched anion exchange membrane and preparation method and application thereof | 安徽大学 | 2024-11-01 | — | — | CN | claimed |
| CN-118431526-A | Organic-organic hybrid anion exchange membrane, preparation method and application | 淮阴师范学院 | 2024-08-02 | — | — | CN | claimed |
| CN-113075343-A | Detection method of hydroxylamine and salt thereof | 东莞市东阳光仿制药研发有限公司 | 2021-07-06 | — | — | CN | claimed |
| CN-118878789-A | Branched anion exchange membrane and preparation method and application thereof | 安徽大学 | 2024-11-01 | — | — | CN | disclosed |
| CN-118431526-A | Organic-organic hybrid anion exchange membrane, preparation method and application | 淮阴师范学院 | 2024-08-02 | — | — | CN | disclosed |
| CN-113075343-B | Hydroxylamine and detection method of hydroxylamine salt | 东莞市东阳光仿制药研发有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-117304708-A | Heptamethine indole cyanine dye and preparation method and application thereof | 中国乐凯集团有限公司 | 2023-12-29 | — | — | CN | disclosed |
| US-20230021224-A1 | METHODS AND COMPOSITIONS OF INHIBITING DCN1-UBC12 INTERACTION | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2023-01-19 | — | — | US | disclosed |
| CN-113659180-B | Anion exchange membrane containing twisted aryl and ketone monomer, adhesive, preparation and application | 中国科学院山西煤炭化学研究所 | 2022-11-25 | — | — | CN | disclosed |
| EP-3495341-B1 | PREPARATION PROCESS OF PERFLUOROALKYL COMPOUND WITH MONOHYDROPERFLUOROALKANE AS STARTING MATERIAL | KANTO DENKA KOGYO KK (JP) | 2022-11-02 | — | — | EP | disclosed |
| CN-109563016-B | Method for producing perfluoroalkyl compound using monohydroperfluoroalkane as starting material | 关东电化工业株式会社 | 2022-05-13 | — | — | CN | disclosed |
| US-4546105-A | ANALGESICS | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1985-10-08 | — | — | US | disclosed |
| EP-0141968-A1 | Pyrrolylaminopiperidines, a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1985-05-22 | — | — | EP | disclosed |
| US-4452803-A | ANALGESICS | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1984-06-05 | — | — | US | disclosed |
| US-4372961-A | REACTING A 3-AMINORIFAMYCIN S WITH A 4-PIPERIDONE, ANTIBIOTICS | BRUZZESE TIBERIO (IT) | 1983-02-08 | — | — | US | disclosed |
| US-4065617-A | ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1977-12-27 | — | — | US | disclosed |
| US-4005208-A | GASTRIC JUICE, ANTISECRETORY | SMITHKLINE CORPORATION (US) | 1977-01-25 | — | — | US | disclosed |
| US-3985889-A | 1,3-DIHYDROSPIRO(ISOBENZOFURAN); ANALGETIC AGENTS | AMERICAN HOECHST CORPORATION (US) | 1976-10-12 | — | — | US | disclosed |
| US-3962259-A | TRANQUILIZERS, ANALGETIC AGENTS | AMERICAN HOECHST CORPORATION (US) | 1976-06-08 | — | — | US | disclosed |
| US-3939159-A | ANTICONVULSANT, CNS DEPRESSANT | AMERICAN HOECHST CORPORATION (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230021224-A1 | METHODS AND COMPOSITIONS OF INHIBITING DCN1-UBC12 INTERACTION | UBQLN1, CUL1, DCUN1D1 | ALDH1A1 1996/4885THRB 4604/4885HPGD 2331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.